Pharma AI Visual Inspection — CDSCO-Compliant

Indian pharma manufacturers face inspection requirements from CDSCO domestically and from FDA, EMA, MHRA, and customer-side audit teams internationally. Manual visual inspection of blister packs, vials, and labels can't deliver the consistency these audits require at production volume. Opsio's pharma AI visual inspection systems replace inspector fatigue with consistent computer-vision verification, with CDSCO-compliant validation paperwork engineered at design time rather than retrofitted at audit. Common deployment surfaces include blister seal integrity (incomplete seals, contamination under seal, misalignment), label inspection (print quality, alignment, batch-number legibility, expiry-date verification), fill-level verification (vials, ampoules, syringes, IV bags), and tamper-evident-band inspection. Each surface uses a model trained on the customer's annotated production images, deployed at the factory edge, and integrated with existing batch-genealogy and MES systems.

CDSCO supplier audit, FDA 21 CFR Part 11 path, and EU GMP Annex 11 compliance documentation is part of the deployment artefact set. Model card, training-data lineage, evaluation report, change-control log, and audit trail for every prediction served — all produced as part of the engagement rather than as a separate compliance project.